Christopher Haqq
2015 - Atara Biotherapeutics
In 2015, Christopher Haqq earned a total compensation of $2.5M as EVP, R&D and Chief Scientific Officer at Atara Biotherapeutics, a 170% increase compared to previous year.
Compensation breakdown
| Bonus | $198,250 |
|---|---|
| Option Awards | $1,562,012 |
| Salary | $381,250 |
| Stock Awards | $311,860 |
| Other | $3,254 |
| Total | $2,456,626 |
Haqq received $1.6M in option awards, accounting for 64% of the total pay in 2015.
Haqq also received $198.3K in bonus, $381.3K in salary, $311.9K in stock awards and $3.3K in other compensation.
Rankings
In 2015, Christopher Haqq's compensation ranked 3,904th out of 13,638 executives tracked by ExecPay. In other words, Haqq earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,904 out of 13,638 | 71st |
Division Manufacturing | 1,422 out of 5,190 | 73rd |
Major group Chemicals And Allied Products | 516 out of 1,854 | 72nd |
Industry group Drugs | 409 out of 1,528 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 71 out of 254 | 72nd |
Source: SEC filing on April 24, 2017.
Haqq's colleagues
We found two more compensation records of executives who worked with Christopher Haqq at Atara Biotherapeutics in 2015.